Notably, a recent study has observed higher ccf-mtDNA levels in the sera of PRKN and PINK1 biallelic mutation carriers and affected heterozygotes compared to patients with sPD, possibly resulting from impaired mitophagy in PRKN/PINK1-associated PD (Borsche et al., 2020). This evidence concerns the gene PRKN and Parkinson disease.